We proudly support programs and offer resources for advocacy groups, healthcare providers, and our local community. In particular, we believe we have an opportunity to make a real impact for patients suffering from chronic kidney disease (CKD) and metabolic acidosis. An estimated 3 million people in the United Stated suffer from later stage CKD and metabolic acidosis. We’re working hard to provide the potential first FDA-approved chronic treatment to help these patients and help slow the progression of CKD.
Tricida has sponsored educational programs and efforts by the National Kidney Foundation (NKF) to expand awareness about the complications and causes of CKD.
We are proud sponsors of the American Kidney Fund (AKF) and have supported the efforts of the Kidney Disease Improving Global Outcomes (KDIGO) organization, a global nonprofit organization that is developing and implementing evidence-based clinical practice guidelines in kidney disease.
If you would like to be part of the effort to help patients with CKD and metabolic acidosis, consider a donation to the NKF, AKF or KDIGO to help support educational efforts and advancements in kidney disease research. To donate, click on the logo and follow the link to the NKF, AKF or KDIGO websites.